Why Most Cannabis Brands Fail to Scale
Scaling cannabis production isn’t just about output. It’s about process, consistency, and building systems that actually hold up under pressure. In cannabis, scaling […]
Scaling cannabis production isn’t just about output. It’s about process, consistency, and building systems that actually hold up under pressure. In cannabis, scaling […]
President Trump signed an executive order on April 18 directing the FDA to fast-track review of psychedelic therapies and committing $50 million […]
As federal cannabis rescheduling looms on the horizon and more states across the country begin rolling out regulations for legal psychedelic therapy, […]
From home labs and deadly butane blasts to solventless rosin, police raids, and a legal gray zone, Spain is entering a more […]
We understand: a huge part of why people are turning to AI for medical advice is because it’s just so accessible. But […]
Jimmy John’s Dream Rotation campaign doesn’t wink at cannabis culture. It hires Cheech Marin, lets him argue with a sandwich and makes […]
Legal cannabis operators paid $2.24 billion in excess federal taxes in 2025. The illicit market paid zero. That is not a coincidence. […]
A survey of more than 1,100 people with suspected or diagnosed CHS offers one of the clearest looks yet at the condition, […]
A decade in, one of New York’s most important cannabis gatherings is doubling down. New York’s cannabis industry doesn’t have many constants. […]
Cannabis brands don’t usually build worlds. They build catalogs, menus, drops. Hypno Seeds has been moving in a different direction—treating cannabis less […]
